Market shift sees $4 trillion move from tech to energy, reshaping investment strategies amid inflationary pressures.

Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Find out ...

India’s ₹10,000 crore Biopharma SHAKTI scheme marks a definitive shift from low-cost generics to high-value biologics, aiming ...

Oil rises, cash gushes—and shareholders get paid. Strong payouts ride the upcycle, but as capex rises, the real question is: ...

Targa Resources is positioned for continued growth, leveraging its dominant Permian Basin midstream footprint and ...

Beyond the war, police arrested a suspect in an alleged Molotov cocktail attack on OpenAI CEO Sam Altman’s home Friday ...

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.

The S&P 500 (^GSPC) and the tech-heavy Nasdaq Composite (^IXIC) gained 0.6% and 0.8%, respectively, extending their daily ...

PLTR stock analysis: How Palantir moved from a 2020 direct listing to an AI bellwether - GAAP profitability, AIP bootcamps, ...

Boris Cherny, the head of Claude Code, almost parted ways with Anthropic for good last summer. Instead, he has helped shape ...

QuantumScape recently announced that Dr. Mark Maybury, a senior technology leader at Lockheed Martin and former U.S. Air Force Chief Scientist, has joined its strategic advisory board. His background ...

Now working under a four-year deal rather than three, the writers got some much-needed healthcare relief, along with added residuals and protections.